Anti-Obesity Drugs: A Review about Their Effects and Safety

New Drug Targets for the Treatment of Obesity

(2011) A G Powell et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

A One-Year Randomized Trial of Lorcaserin for Weight Loss in Obese and Overweight Adults: The BLOSSOM Trial

(2011) Meredith C. Fidler et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Randomized controlled trial to investigate the effects of a newly developed formulation of phentermine diffuse-controlled release for obesity

(2010) J. G. Kang et al.   DIABETES OBESITY & METABOLISM

Fatal and Non-Fatal Cardiovascular Events in a General Population Prescribed Sibutramine in New Zealand

(2010) Mira Harrison-Woolrych et al.   DRUG SAFETY

A clinical trial assessing the safety and efficacy of taranabant, a CB1R inverse agonist, in obese and overweight patients: a high-dose study

(2010) L J Aronne et al.   INTERNATIONAL JOURNAL OF OBESITY

A clinical trial assessing the safety and efficacy of the CB1R inverse agonist taranabant in obese and overweight patients: low-dose study

(2010) J Proietto et al.   INTERNATIONAL JOURNAL OF OBESITY

Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

(2010) Frank L Greenway et al.   LANCET

Drug Management of Obesity — Efficacy versus Safety

(2010) Arne Astrup   NEW ENGLAND JOURNAL OF MEDICINE

Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management

(2010) Steven R. Smith et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects

(2010) W. Philip T. James et al.   NEW ENGLAND JOURNAL OF MEDICINE

Weight Loss With Naltrexone SR/Bupropion SR Combination Therapy as an Adjunct to Behavior Modification: The COR-BMOD Trial

(2010) Thomas A. Wadden et al.   Obesity

A randomized double-blind placebo-controlled study of the long-term efficacy and safety of diethylpropion in the treatment of obese subjects

(2009) C Cercato et al.   INTERNATIONAL JOURNAL OF OBESITY

Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study

(2009) Arne Astrup et al.   LANCET

Weight Loss, HbA1cReduction, and Tolerability of Cetilistat in a Randomized, Placebo-controlled Phase 2 Trial in Obese Diabetics: Comparison With Orlistat (Xenical)

(2009) Peter Kopelman et al.   Obesity

The Acyclic CB1R Inverse Agonist Taranabant Mediates Weight Loss by Increasing Energy Expenditure and Decreasing Caloric Intake

(2008) Carol Addy et al.   Cell Metabolism

Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With Metformin, in Type 2 Diabetes: The LEAD (Liraglutide Effect and Action in Diabetes)-2 study

(2008) M. Nauck et al.   DIABETES CARE

The epidemiology of obesity: the size of the problem

(2008) W. P. T. James   JOURNAL OF INTERNAL MEDICINE

Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial

(2008) Arne Astrup et al.   LANCET

Weight Loss Produced by Tesofensine in Patients With Parkinson's or Alzheimer's Disease

(2008) Arne Astrup et al.   Obesity

Orlistat and sibutramine beyond weight loss

(2007) Edoardo Mannucci et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Prevalence of obesity and metabolic syndrome in Korean adults

(2007) H. S. Park et al.   Obesity Reviews